Background Helicobacter pylori is one of the most common gastric pathogens, affecting at
least half the world's population, and is strongly associated with gastritis, peptic ulcer, gastric …

Data are available such that choice of Helicobacter pylori therapy for an individual patient
can be reliably predicted. Here, treatment success is defined as a cure rate of 90% or …

Background Helicobacter pylori (H. pylori) is the causative agent of stomach diseases such
as duodenal ulcer and gastric cancer, in this regard incomplete eradication of this bacterium …

Gastric cancer is associated with high morbidity and mortality worldwide. To reduce the
socioeconomic burden related to gastric cancer, it is very important to identify and manage …

Abstract Background The effect of Helicobacter pylori (H. pylori) eradication on gastric
cancer (GC) prevention is controversial. Intestinal metaplasia (IM) seems to be a “point of no …

Background Atrophic gastritis and intestinal metaplasia are premalignant conditions for
gastric cancer. Their reversibility by Helicobacter pylori eradication remains controversial …

Gastric cancer, 1 of the 5 most common causes of cancer death, is associated with a 5-year
overall survival rate less than 30%. A minority of cancers occurs as part of syndromic …

The accurate detection of Helicobacter pylori (H. pylori), a major cause of gastric cancer, is
essential for managing infected patients. Among various diagnostic methods, histology plays …

Background Proton pump inhibitors (PPI s) have a well‐established safety profile. However,
concerns have been raised about a potential relationship between PPI‐induced …

Helicobacter pylori (H. pylori) affects nearly half of the world's population and, thus, is one of
the most frequent and persistent bacterial infections worldwide. H. pylori is associated with …